Poll: Nearly half of medtech women executives’ companies ready for pandemic’s second wave
Nearly half of medtech executives polled in a recent survey said their companies are prepared for the second wave of the COVID-19 pandemic that is sweeping the globe. ...Participants at the virtual MedExecWomen forum included, clockwise from top left, Anjana Harve, Fresenius; Jodi Eddy, Boston Scientific; moderator Meghna Eichelberger, Boston Consulting Group; and Harvard lecturer Luba Greenwood, senior advisor to CEO, Dana Farber Cancer Institute.